CD4 and diffuse large B-cell lymphoma: After running DXM on each DLBCL sample, we first compared DXM-solved estimates (using a gene signature from normal CD4+T and GCB cells as above) of the relative proportion of T and B cells, to T and B cell proportions determined by FACS and to clinical flow cytometry.